NFE2L2 and cancer: Sova and Saso have reviewed in depth several design approaches used to develop NRF2 modulators.13 They have also focused on the most important and recently developed NRF2 activators and inhibitors, their in vitro and in vivo research, and their potential utility as cancer therapies or chemopreventive drugs.